SUSQUEHANNA INTERNATIONAL GROUP, LLP - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$68,022,557
+6.7%
1,788,185
+155.6%
0.01%
+7.7%
Q2 2023$63,743,581
+24.5%
699,710
-9.9%
0.01%
+18.2%
Q1 2023$51,211,080
+125.8%
776,396
+77.0%
0.01%
+120.0%
Q4 2022$22,676,490
-11.1%
438,532
+17.4%
0.01%
-28.6%
Q3 2022$25,521,000
+261.1%
373,660
+139.1%
0.01%
+250.0%
Q2 2022$7,067,000
-64.5%
156,280
-60.1%
0.00%
-50.0%
Q1 2022$19,919,000
-5.8%
392,035
-12.4%
0.00%
Q4 2021$21,156,000
-53.7%
447,498
-67.7%
0.00%
-100.0%
Q3 2021$45,725,000
-26.2%
1,387,310
+41.5%
0.01%
-37.5%
Q2 2021$61,966,000
+498.4%
980,469
+306.3%
0.01%
+300.0%
Q1 2021$10,355,000
-47.4%
241,323
-29.8%
0.00%0.0%
Q4 2020$19,670,000
+308.1%
343,880
+115.3%
0.00%
Q3 2020$4,820,000
-31.7%
159,743
-26.1%
0.00%
-100.0%
Q2 2020$7,057,000
-14.7%
216,061
-30.0%
0.00%0.0%
Q1 2020$8,272,000
-34.5%
308,794
-25.1%
0.00%
-33.3%
Q4 2019$12,629,000
+240.1%
412,432
+167.5%
0.00%
+50.0%
Q3 2019$3,713,000
+109.5%
154,198
+120.4%
0.00%
Q2 2019$1,772,00069,9520.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders